STRATA Skin Sciences, Inc. (SSKN) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -239K | -64K | -1.94M | -550K | 703K | -302K | 591K | -804K | 1.51M | -997K | 175K | -1.2M |
| Operating CF Margin % | -2.57% | -0.92% | -25.33% | -8.07% | 7.34% | -3.43% | 7.01% | -11.9% | 17.33% | -11.26% | 2.12% | -15.9% |
| Operating CF Growth % | -134% | 78.81% | -428.43% | 31.59% | -53.32% | 69.71% | 237.71% | 33.17% | 30220% | -43.66% | 412.5% | -240.79% |
| Net Income | 58K | -1.62M | -2.49M | -2.43M | -4.5M | -2.12M | -99K | -3.37M | -3.79M | -1.05M | -3.15M | -2.83M |
| Depreciation & Amortization | 906K | 951K | 1.3M | 1.3M | 1.31M | 1.32M | 1.33M | 1.34M | 1.37M | 1.54M | 1.49M | 1.5M |
| Stock-Based Compensation | 174K | 0 | 128K | 129K | 126K | 26K | 163K | 112K | 289K | 337K | 352K | 325K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 890K | 0 |
| Other Non-Cash Items | -390K | -238K | 124K | 183K | 3.6M | -12K | -9K | 269K | 2.3M | -7K | 42K | -54K |
| Working Capital Changes | -987K | 845K | -1.01M | 265K | 156K | 486K | -793K | 839K | 1.34M | -1.81M | 548K | -141K |
| Change in Receivables | -630K | 568K | 929K | 136K | -668K | -394K | -295K | 726K | 267K | -334K | -418K | 626K |
| Change in Inventory | 342K | 282K | -535K | -377K | 558K | 8K | 160K | -154K | 1.03M | -72K | -169K | -103K |
| Change in Payables | -124K | 9K | 103K | 362K | 684K | -1.17M | -727K | 261K | 168K | -619K | 677K | -326K |
| Cash from Investing | -312K | -1.02M | 61K | -199K | -504K | -62K | -345K | -725K | -1.85M | -829K | -931K | -1.41M |
| Capital Expenditures | -312K | -1.02M | 61K | -199K | -504K | -62K | -345K | -725K | -1.85M | -829K | -931K | -1.41M |
| CapEx % of Revenue | 3.36% | 14.69% | 0.8% | 2.92% | 5.26% | 0.7% | 4.09% | 10.73% | 21.33% | 9.37% | 11.28% | 18.58% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 1.39M | 2.19M | 0 | 0 | 0 | 1.94M | 0 | -18K | 0 | -104K | 6.96M | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -97K | 0 | 0 |
| Equity Issued (Net) | 1.39M | 2.19M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 1.94M | 0 | -18K | 0 | -7K | 6.96M | 0 |
| Net Change in Cash | 836K | 1.11M | -1.88M | -749K | 199K | 1.58M | 246K | -1.55M | -347K | -1.93M | 6.21M | -2.61M |
| Free Cash Flow | -551K | -1.08M | -1.88M | -749K | 199K | -364K | 246K | -1.53M | -347K | -1.83M | -756K | -2.61M |
| FCF Margin % | -5.93% | -15.62% | -24.53% | -11% | 2.08% | -4.14% | 2.92% | -22.64% | -3.99% | -20.63% | -9.16% | -34.48% |
| FCF Growth % | -376.88% | -197.25% | -864.23% | 51.01% | 157.35% | 80.07% | 132.54% | 41.4% | 77.17% | -49.55% | 14.77% | -152.81% |
| FCF per Share | -0.09 | -0.02 | -0.05 | -0.02 | 0.01 | -0.01 | 0.01 | -0.04 | -0.01 | -0.05 | -0.02 | -0.07 |
| FCF Conversion (FCF/Net Income) | -4.12x | 0.04x | 0.78x | 0.23x | -0.16x | 0.14x | -5.97x | 0.24x | -0.40x | 0.95x | -0.06x | 0.42x |
| Interest Paid | 0 | 0 | 457K | 0 | 483K | 500K | 0 | 0 | 498K | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |